(Q86999674)

English

Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

scientific article published on 24 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

9

object named as

Deborah A Kuban

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Lawrence B Levy

2

object named as

Lawrence B Levy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Karen E Hoffman

8

object named as

Karen Hoffman

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Seungtaek L Choi

4

object named as

Seungtaek S Choi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Thomas A.M. Pugh

6

object named as

Thomas J Pugh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sean E. McGuire

7

object named as

Sean McGuire

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

object named as

Steven J Frank

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Quynh-Nhu Nguyen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Andrew K Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

24 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

3265-3271

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptomatic local recurrence of prostate carcinoma after radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28213

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28213

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798338%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86999674&oldid=2058330762"